About this trial
The aim of this study is to evaluate the prognostic utility of the red cell distribution width/albumin ratio (RAR), measured within 24 hours of hospital admission, in predicting 30-day mortality among patients with burn injuries.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age > 18 years.
Both sexes.
Patients with burn injuries (%TBSA >20%).
Availability of complete laboratory data (RDW, albumin) on admission.
Disqualifiers
Age <18 years.
Patients with chronic hematologic disease.
Pre-existing liver disease.
Nephrotic syndrome.
Trial population
Patients presenting with acute thermal injuries will be screened based on inclusion/exclusion criteria. After consent, Patients' characteristics (age, sex, weight), clinical parameters (Total burn surface area, Abbreviated burn severity index), and comorbidities will be recorded.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
mortality in burn patients
To determine the correlation between Red Cell Distribution Width/Albumin on admission and 30 days hospital mortality in burn patients.
Secondary outcomes
ICU length of stay
To determine the correlation between Red Cell Distribution Width/Albumin with o ICU length of stay
To compare RDW/albumin ratio with Revised Baux score as a predictor of mortality in burn patient.
Revised Baux score = (percent body surface burned) + (patient's age) + 17 (if inhalational injury is present) A higher Revised Baux score generally indicates a higher risk of mortality, with scores over 140 unsurvivable .
Requirements of inotropes or vasopressors
To determine the correlation between Red Cell Distribution Width/Albumin with o Requirements of inotropes or vasopressors
Duration of mechanical ventilation
To determine the correlation between Red Cell Distribution Width/Albumin with o Duration of mechanical ventilation
Sponsors and contacts
Click on the lead sponsor to view all of their trials.